BACKGROUND: Poor vein visibility can make IV cannulation challenging in children with dark skin color. In the operating room, we studied the effectiveness of a near-infrared vascular imaging device (VascuLuminator) to facilitate IV cannulation in children with dark skin color. METHODS: In the operating room of a general hospital in Curacao, all consecutive children (0-15 years of age) requiring IV cannulation were included in a pragmatic cluster randomized clinical trial. The VascuLuminator was made available to anesthesiologists at the operating complex in randomized clusters of 1 week. RESULTS: Success at first attempt was 63% (27/43, 95% confidence interval [CI], 47%-77%) in the VascuLuminator group vs 51% (23 of 45 patients, 95% CI, 36%-66%) in the control group (P = 0.27). Median time to successful cannulation was 53 seconds (interquartile range: 34-154) in the VascuLuminator group and 68 seconds (interquartile range: 40-159) in the control group (P = 0.54), and hazard ratio was 1.12 (95% CI, 0.73-1.71). CONCLUSION: The VascuLuminator has limited value in improving success at first attempt of facilitating IV cannulation in children with dark skin color.
P erforming IV cannulation in children can be difficult; even in a specialized pediatric hospital, the success at first attempt was only 70% in patients under general anesthesia. 1 Infants have tiny veins and a thick layer of subcutaneous fat, which can make identification and localization of veins difficult. Dark skin color adds further difficulty, because of the low contrast between veins and skin color. 2 The Department of Medical Technology and Clinical Physics at the University Medical Center Utrecht developed a noninvasive near-infrared vascular imaging device (VascuLuminator, De Koningh Medical Systems, Arnhem, NL), which might facilitate venipuncture and IV cannulation, particularly in children with dark skin color. The device uses transillumination with near-infrared light to visualize veins regardless of the color of the skin, including those that would otherwise not be visible. 3 An explorative study with a prototype of the VascuLuminator showed promising results in facilitating venipuncture in children aged 6 years and younger, but for improving the success rate of IV cannulation in a randomized clinical trial the device showed inconclusive results in unselected pediatric patients. 3, 4 However, most patients in that study had a light skin color, whereas the VascuLuminator was specially devised for children with dark skin color. Therefore, we hypothesized that in darkskinned children the device would likely be more effective in facilitating IV cannulation by increasing the success rate at first attempt and reducing the time to successful cannulation using the VascuLuminator compared with the standard technique. In a population of children with predominantly dark skin color undergoing surgery, we studied the effect of using the VascuLuminator on success rate and time to IV cannulation in comparison with routine clinical practice (a control group without device assistance).
METHODS
The study design was approved by the Medical Ethics Committee of the St. Elisabeth Hospital, which waived the need for informed consent. There was no burden on the subjects because IV cannulation was already required, and there were no risks associated with the use of the device.
The present cluster randomized clinical trial was performed in a primary general hospital at Curacao in the Caribbean (St. Elisabeth hospital, Willemstad, Curacao, Caribbean Sea). All consecutive children scheduled for surgery, in which IV The Effectiveness of a Near-Infrared Vascular Imaging Device to Support Intravenous Cannulation in Children with Dark Skin Color: A Cluster Randomized Clinical Trial cannulation was planned during working hours (7:30 am-4:00 pm) at the operating room of the St. Elisabeth Hospital, were prospectively included in the study from February 2011 until May 2011. The indication for the need for IV cannulation was left to the discretion of the treating anesthesiologist and was not influenced by the present study.
The aim of the present study was to study the effectiveness of the VascuLuminator in a population with a predominantly dark skin color. The present study was performed in Curacao, because about 85% of the population of Curacao has dark skin color. The availability of the VascuLuminator to anesthesiologists at the operating complex was randomized by computer in clusters of 1 week. In the VascuLuminator group IV cannulation was aided by the device, whereas the device was not available at the operating room in the control group. IV cannulation (BD Venflon 18, 20, 22, 24 G or BD Insyte with BD Vialon biomaterial 24 G, BD, Franklin Lakes, NJ or Terumo Surflo [winged and ported] 22G, Terumo, Somerset, NJ) was typically performed after the child had been anesthetized using inhaled induction with sevoflurane by facemask. The exact type of cannula used was dependent on availability (at the time of study, there was a materials supply problem in the hospital). If the patient requested IV induction of anesthesia (mostly older children), a local anesthetic (eutectic mixture of lidocaine and prilocaine, AstraZeneca, Södertälje, Sweden) was applied and covered with a plastic foil dressing for at least 60 minutes before awake cannulation.
The anesthesiologists (5 trained in the Netherlands and 2 in Colombia) worked in Curacao for at least 3 years and were not experienced with the use of any near-infrared imaging system for vein visualization.
In both groups, preparations for IV cannulation were performed as usual; a tourniquet was placed above the puncture site, veins were thumped or tapped if required, the arm or leg was left hanging downwards, and alcohol was applied as a disinfectant and to improve contrast between skin and vein. During the study period, no other assist devices (e.g., ultrasonography or visual transilluminator) were available.
The veins were visualized with the VascuLuminator, which is based on transillumination of near-infrared light as described elsewhere. 3 In short, a small near-infrared light source is used to transilluminate the puncture site. The nearinfrared light, invisible to the human eye, is processed by a near-infrared-sensitive camera and projected on a display, located above the puncture site ( Fig. 1 ). The anesthesiologist performing the IV cannulation could use the device as an assistive tool for guidance, because normal inspection and palpation of the puncture site are not hampered by the device.
Before the start of the study, there was an introduction period with the VascuLuminator and anesthesiologists received a short training. The VascuLuminator is designed to be intuitive in use, and the image on the screen is clear and easily interpretable. Therefore, it was not deemed necessary to implement long training sessions before the start of the study.
In weeks that the VascuLuminator was allocated, the performer was obliged to use the VascuLuminator device to visualize the veins before the start of the IV cannulation, but it was left to the discretion of the performer whether to use the device during the actual IV cannulation. In the control group, IV cannulation took place as usual without guidance from the VascuLuminator. All punctures were performed by an anesthesiologist as scheduled by the operating scheme. The primary outcome of interest was success at first attempt, which was defined as the percentage of procedures in which the IV cannulation succeeded at the first attempt. An attempt was defined as a penetration with a needle through the skin. Secondary outcomes of interest were time to successful cannulation, whether the procedure succeeded, and helpfulness of the VascuLuminator (as perceived by the operator). Time measurement of the procedure started at the moment the performer initiated the search for a suitable vessel by palpating or looking (with the device, when assigned) and ended at the moment the IV line was flushed or the procedure was aborted. A successful procedure was defined as an IV cannula successfully placed in a vein, which could be flushed without restriction. All observations were performed by 1 independent researcher (OCPvdW). The helpfulness of the VascuLuminator was determined by the performer of the IV cannulation in 3 grades: helpful, partly helpful, or not helpful. "Helpful" was used when cannulation probably would not have been successful without the use of the device; "partly helpful" if the performer was of the opinion that the device aided the puncture, but the cannulation would probably also have succeeded without help of the device; and "not helpful" if cannulation was successful without any contribution of the device, or that the device probably had interfered with successful cannulation. In addition, height and weight of the patient, skin color, anticipated difficulty, and puncture site were registered. The skin color was determined by the researcher on a description and photo samples according to the Fitzpatrick skin type 
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Near-Infrared Vascular Imaging in Children with Dark Skin scale, a 6-point scale in which type I is very light skin color and type VI is black-brown skin ( Table 1) . 5, 6 Fitzpatrick skin type 5 and 6 were considered to be dark skin color.
The anticipated difficulty was determined by the performer of the IV cannulation in consultation with the observing researcher before the start of the procedure and was graded: very easy (vessel clearly visible and palpable without tourniquet), easy (vessel visible and palpable after placing a tourniquet), average (vessel visible and palpable after tapping), hard (vessel hardly visible or palpable after tapping), or very hard (vessel not visible nor palpable). A priori, subgroup analyses was performed in patients difficult to puncture (including patients rated hard and very hard) and age (age <3 years) that are difficult to puncture. 1,2
Sample Size
Yen et al. 2 showed that dark-skinned people are more difficult to cannulate. From a previous study, we knew that the success at first attempt of IV cannulation in children with predominantly white skin color was 70%. 1 We assumed the success at first attempt to be lower (50%) in a population with predominantly dark skin color. Assuming that success at first attempt would increase from 50% to 80% in the VascuLuminator group (30% risk reduction for failed IV cannulation), the estimated required sample size was 90 patients (2 groups of 45, α = 0.05, power = 0.80).
Statistics
Continuous data were presented with mean and SD or median and interquartile range (IQR), if appropriate. Dichotomous data were presented as a ratio to the total and a percentage. Success at first attempt was evaluated using a χ 2 test.
Differences in time to successful cannulation were tested with a Mann-Whitney U test and a negative binomial model to construct a 95% confidence interval (CI). P < 0.05 was considered to be statistically significant for the primary endpoint and <0.01 for subgroup analyses. All statistical analyses were performed using SPSS statistics version 20 (SPSS, Chicago, IL) with exception of the 95% and 99% CIs of risk differences that were calculated with Confidence Interval Analysis (version 1.0, University of Southampton, Southampton, UK).
RESULTS
In total, 111 children underwent surgery in the operating room during working hours from February 1, 2011 until May 13, 2011. Five children were excluded from the study because they already had an IV cannula in situ, and 18 children were excluded because they did not need an IV cannula. Eighty-eight patients were included in the study (45 patients in the control group and 43 patients in the VascuLuminator group, Fig. 2 ). Patient characteristics were equally distributed between groups ( Table 2 ). Seven different anesthesiologists performed the IV cannulations, and all cannulations were successful.
Success at first attempt was not significantly (P = 0.27) higher in the VascuLuminator group (27/43, 63;%, 95% CI, 47%-77%) than in the control group (23/45, 51%; 95% CI, 36%-66%; Table 3 ). Median time to successful cannulation was 53 seconds (IQR: 34-154) in the VascuLuminator group and 68 seconds (IQR: 40-159) in the control group (P = 0.54, Fig. 3 ). The "risk" of a briefer time when using the VascuLuminator was 12% (β-coefficient of GLM analyses: 1.12, 95% CI, 0.71-1.78). Figure 4 shows success at first attempt over a period of time for a subsequent group of 30 patients. In the subgroup of children a priori anticipated to be difficult to cannulate ("hard" or "very hard"), there was a trend to higher success at first attempt in the VascuLuminator group (8/16, 50%, 99% CI, 19%-81%) than in the control group (1/13, 8%; 99% CI, 0%-45%; P = 0.03; Table 3 ). Median time to successful cannulation was 102 seconds (IQR: 40-664) in the VascuLuminator group and 310 seconds (IQR: 132-660) in the control group (P = 0.07) in this subgroup anticipated to be difficult to cannulate. In the subgroup of children younger than 3 years of age, the success rate at first attempt was 14 of 23 (61%) in the VascuLuminator group and 8 of 23 (35%) in the control group (P = 0.08, Table 3) ; median time to successful cannulation was 66 seconds (IQR: 40-248) in the VascuLuminator group vs 120 seconds (IQR: 47-390) in the control group (P = 0.21).
The VascuLuminator was deemed helpful by the performer in 20 of 43 cases and partly helpful in 9 of 43 cases. The other subgroups (awake patients, with and without eutectic mixture of lidocaine and prilocaine, and various needles) were too small to draw any meaningful conclusion.
DISCUSSION
In the present study in a population of children with dark skin color, we observed that the VascuLuminator has limited value in improving the success at first attempt compared with IV cannulation without the use of any device. However, in the subgroup of children anticipated to be difficult to cannulate, there was a trend in improvement in success at first attempt when the VascuLuminator was used. The present study did not show a significant improvement in the general population of dark-skinned children. Previous evaluations of various types of near-infrared vascular imaging devices did not show any additional clinical value. In a previous randomized clinical trial evaluating the clinical value of the VascuLuminator before surgery in 494 unselected children with predominantly light-colored skin, our group was unable to demonstrate an improved success rate of IV cannulation. 4 Evaluations of another device (VeinViewer, Christie Medical Innovations, Memphis, TN) were inconclusive; a clinical evaluation of the VeinViewer in 323 children receiving IV cannulation at an emergency department showed an improvement in IV cannulation in children younger than 2 years of age, whereas another study, also at an emergency department (n = 123), showed no difference in first-attempt success rate between the standard approach and use of the device. 7, 8 Another clinical trial in 600 children was aborted because the VeinViewer appeared to have a negative effect on the 
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Near-Infrared Vascular Imaging in Children with Dark Skin success rate of IV cannulation. 9 Cuper et al. 10 showed that the VascuLuminator does not significantly improve the time and success rate of arterial cannulation in small children, although there is a tendency in favor of success at first attempt and a reduction in number of punctures. Yen et al. 2 showed that skin color is a predictor for difficult cannulation although this was not confirmed in a reassessment of the Diva score by Riker et al. 11 A previous study with the VascuLuminator assisting IV cannulations, performed in a tertiary pediatric hospital in the Netherlands, showed no difference in success at first attempt (70% vs 71%) or time to successful cannulation between the VascuLuminator group and the control group. 4 The population in the present study, consisting of patients with dark skin color, is considerably more difficult to cannulate (success at first attempt 51% without the VascuLuminator) than the patients in the previous study. It can be speculated that visualization of veins with near-infrared light seems to be useful in children in whom it is hard to locate the veins with the naked eye and is likely not useful in children whose veins are already visible (as was the situation in the previous study). 4 There are some limitations to the present study. First, the clinical effect was smaller than anticipated for the sample size calculation, and therefore the sample size was too small to show a statistically significant effect on the primary outcome. Because there were no prior data available on success at first attempt in a population of children with dark skin color, a complete sample size calculation could not be performed. Nevertheless, in the subgroup analysis of children with previously anticipated difficulty, the effect of the VascuLuminator on first-attempt success was clinically relevant. Second, because 85% of the population at Curacao has dark skin color, we assume that the anesthesiologists in Curacao are more experienced in performing IV cannulations on children with dark skin color than anesthesiologists working in areas with a pediatric population that is predominantly light skinned. Therefore, the results of the present study are probably not generalizable to anesthesiologists not used to a population of children with dark skin color, in whom initial success in this population is likely to be lower and the advantage of the use of VascuLuminator might be larger.
Third, the principal predictor of success at first attempt and time to successful cannulation is the provider, not the patient. Seven different anesthesiologists performed the cannulations during the study. All anesthesiologists were experienced (at least 3 years of working experience in Curacao) in performing IV cannulation in children. However, no track record was kept regarding which anesthesiologist performed which IV cannulation. We cannot exclude the possibility of a learning curve, although this is not likely given the change in success at first attempt over time (Fig. 4) .
Fourth, there were several variances in the present study that might have decreased the internal validity of the study, such as the variety in patients (skin color and sedation state) and IV cannulas. Furthermore, the effect on success at first attempt of IV cannulation of the VascuLuminator was smaller than we assumed. Therefore, we recommend performing an additional study in a specific group, because the VascuLuminator seems to be possibly helpful in facilitating IV cannulation in children younger than 3 years of age or a priori anticipated to be difficult to cannulate. To accurately estimate the benefits of using VascuLuminator to cannulate veins in children with dark skin color, a new study with a larger sample size would be necessary. On the basis of the present observations (increase of success at first attempt from 51% to 63%) a cohort of 566 patients would be needed to confirm or refute the advantage of the VascuLuminator with an α of 0.05 and a power of 0.80. When the study would be performed in dark-skinned children younger than 3 years of age, with an improvement of the success at first attempt from 35% to 61%, the sample size should be 130 patients (α = 0.05, power = 0.80).
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